Doctors and physicians have many options on where to work, but not all locales are created equally when it comes to the best places in which to practice. Factors such as opportunity, competition and the overall medical environment can result in differe…
Since it passed in 2010, the Affordable Care Act has reduced the uninsured rate in the U.S. by nearly half, and one of the biggest trends to occur during this time is the narrowing of coverage gaps for racial and ethnic minority groups, especially in s…
Northwell Health has announced an agreement with medical records software company Epic to implement the health system’s next generation electronic health record.
Northwell said the initiative is part of an ongoing digital transformation to
provide an …
In a sign of growing interest in the pharmacy field, the American Society of Health System Pharmacists issued a report showing that 4,890 people matched with 2,162 pharmacy residency programs across the country during Phase I of ASHP’s 2023 Pharmacy Re…
People are shifting away from traditional primary care providers, with about three in 10 foregoing primary care altogether between 2016 and 2022, according to FAIR Health’s new analysis of private claims data.
The Medicare Advisory Payment Commission recommends a higher-than-current-law fee-for-service payment update in 2024 for acute care hospitals and positive payment updates for clinicians paid under the physician fee schedule.
Optum Health has named Caitlin Zulla CEO of the company’s East Region, promoting her after a three-year stint as CEO of SCA Health, a surgery center chain owned by Optum.
Since joining in 2015 to lead revenue cycle operations, Zulla advanced to be Chie…
The Centers for Medicare and Medicaid Services on Wednesday released the parameters for the first year of prescription drug negotiations to lower prices in Medicare.
The negotiations will affect only Medicare Part D for the first two years, for ten dr…
The White House and the Department of Health and Human Services have announced the names of the first set of Part B prescription drugs that will be subject to Medicare inflation rebates because they raised their prices faster than inflation.
One of the…
Danish pharmaceutical company Novo Nordisk has announced it is lowering the U.S. list prices of several insulin products by up to 75% for people living with Type 1 and type 2 diabetes.
It becomes the second drugmaker to do so, following Eli Lilly’s an…
